Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MethylGene and Taiho enter HDAC inhibitor collaboration

Oct. 23, 2003

Celera Diagnostics enters research collaboration with Merck & Co.

Oct. 23, 2003

Xyotax dose amended in STELLAR 4 trial

Oct. 22, 2003

New FTase inhibitors prepared and tested by scientists at Servier

Oct. 22, 2003

KIT as a potential target for postradiation sarcoma

Oct. 21, 2003

Pintex publishes data supporting Pin1 as a prognostic marker and therapeutic target in cancer

Oct. 21, 2003

AstraZeneca presents four novel series of CDK inhibitors

Oct. 21, 2003

IDM to coordinate Europe project for optimization of prostate cancer vaccine

Oct. 20, 2003

AstraZeneca and Abgenix enter cancer antibody alliance

Oct. 20, 2003

Sunesis acquires exclusive rights to SPC-595

Oct. 17, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...